Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot Study of Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm

Trial Profile

Pilot Study of Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 19 Apr 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Caffeine citrate (Primary)
  • Indications Hypoxia
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2018 New trial record
    • 20 Jan 2014 According to results published in the JAMA Pediatrics Journal, the final sample size of 100 infants was based on an interim analysis performed after the first 20 infants were enrolled.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top